Episode
NEW CPU: PMB Bleed Eval
- Published
- Apr 18, 2026
- Duration seconds
- 1166
- Processing state
processed
Actions
POST https://stenobird.com/v1/public/podcasts/dr-chapa-s-obgyn-clinical-pearls-334380/episodes/new-cpu-pmb-bleed-eval/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/dr-chapa-s-obgyn-clinical-pearls-334380/new-cpu-pmb-bleed-eval.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In the ACOG CO 734 from 2018, it states, “Transvaginal ultrasonography usually is sufficient for an initial evaluation of postmenopausal bleeding if the ultrasound images reveal a thin endometrial echo (less than or equal to 4 mm), given that an endometrial thickness of 4 mm or less has a greater than 99% negative predictive value for endometrial cancer”. But medicine moves fast. This is NO LONGER the guideline. In this episode, we will summarize the new ACOG CPU on the primary evaluation of a patient with postmenopausal vaginal bleeding. Is ultrasound still the single first line test used for evaluation? Listen in for details. 1. Updated Guidance Regarding The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding 2. The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding